Is Kura Oncology (KURA) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 11/22/22
Wall Street Analysts Think Kura Oncology (KURA) Could Surge 116%: Read This Before Placing a BetZacks Investment Research • 11/14/22
Is Kura Oncology (KURA) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 11/03/22
Kura Oncology Announces Four Abstracts Accepted for Presentation at ASH Annual MeetingGlobeNewsWire • 11/03/22
Kura Oncology Reports Preliminary Proof of Mechanism in Phase 1/2 Clinical Trial of Tipifarnib Plus Alpelisib in Head and Neck Squamous Cell CarcinomaGlobeNewsWire • 10/26/22
Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
Kura Oncology to Participate in Wedbush PacGrow Healthcare Virtual ConferenceGlobeNewsWire • 08/02/22
Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/05/22
Kura Oncology Reports Preclinical Data Supporting Use of Tipifarnib to Prevent Emergence of Resistance to Osimertinib in Non-Small Cell Lung CancerGlobeNewsWire • 04/08/22
Kura Oncology Announces Multiple Abstracts Accepted for Presentation at AACR Annual MeetingGlobeNewsWire • 03/08/22
Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22